[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339481-105":59,"doc-detail-339481-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-hdac2-sensitises-antitumour-therapy-by-promoting-nlrp3gsdmd-mediated-pyroptosis-in-colorectal-cancer","Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer","","The study investigates the mechanism by which pyroptosis enhances antitumour therapy in colorectal cancer (CRC), focusing on epigenetic regulation of NLRP3. Pyroptosis in CRC cells treated with antitumour agents was evaluated using Western blotting, LDH release, and microscopy, while chromatin accessibility and promoter histone modifications were analyzed with ATAC-seq, RNA-seq, and ChIP-qPCR. Xenograft and patient-derived xenograft models validated drug combinations. NLRP3 silencing restricts GSDMD-mediated pyroptosis, whereas HDAC2-driven suppression limits NLRP3 transcription via H3K27 acetylation and BRD4/p-P65 complex formation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-hdac2-sensitises-antitumour-therapy-by-promoting-nlrp3gsdmd-mediated-pyroptosis-in-colorectal-cancer/339481/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-hdac2-sensitises-antitumour-therapy-by-promoting-nlrp3gsdmd-mediated-pyroptosis-in-colorectal-cancer/339481.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is pyroptosis considered important for antitumour therapy in colorectal cancer?","Question",{"text":112,"@type":113},"Activated pyroptosis can enhance antitumour efficacy in multiple cancers, but the precise mechanism in colorectal cancer is unclear. This work targets that missing mechanistic link.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study assess pyroptosis in colorectal cancer cells?",{"text":117,"@type":113},"Pyroptosis after antitumour treatment was evaluated using Western blotting, lactate dehydrogenase (LDH) release assays, and microscopy.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does HDAC2 play in regulating NLRP3 and pyroptosis?",{"text":121,"@type":113},"HDAC2 suppresses NLRP3 transcription through epigenetic regulation, limiting NLRP3-dependent, GSDMD-mediated pyroptosis. Inhibiting HDAC2 activates pyroptosis and improves therapeutic effects, supported by molecular and in vivo evidence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339481,1790393407,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","DOI: 10.1002/ctm2.1692  \nRESEARCH ARTICLE  \nInhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer  \nXin Guan1,2, 3  Yuanyu Liao1,2, 3  \nRuiqi Liu4  Bojun Wang1,2, 3  Yuli Ruan1,2, 3  Lin Fang5  \nRuxin Xiong1,2, 3  Luying Cui1,2, 3 Xiaolin Lu6  Xuefan Yu1,2, 3   \nDan Su1,2, 3  Yue Ma1,2, 3  Tianjiao Dang1,2, 3  Zhuo Chen1,2, 3  Yuanfei Yao1,2, 3  Chao Liu1,2, 3  Yanqiao Zhang1,2, 3   \n1 Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China  \n2 Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China  \n3 Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China  \n4 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China  \n5 Phase I Clinical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China  \n6 Department of Orthopedic Surgery, Harbin Medical University Cancer Hospital, Harbin, China  \nCorrespondence  \nYanqiao Zhang, Chao Liu and Yuanfei Yao, Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150001, China. Email: yan[qiaozhang@ems.hrbmu.edu.cn](qiaozhang@ems.hrbmu.edu.cn);  \n[liuchao@hrbmu.edu.cn](liuchao@hrbmu.edu.cn); [yaoyuanfei@hrbmu.edu.cn](yaoyuanfei@hrbmu.edu.cn)  \nGraphical Abstract  \nHighlights  \n∙ Silencing of NLRP3 limits the GSDMD-dependent pyroptosis in colorectal cancer.  \n∙ HDAC2-mediated histone deacetylation leads to epigenetic silencing of NLRP3 .  \n∙ HDAC2 suppresses the NLRP3 transcription by inhibiting the formation of H3K27ac/BRD4/p-P65 complex.  \n∙ Targeting HDAC2 activates pyroptosis and enhances therapeutic effect.  \nClin. Transl. Med. 2024;14:e1692 .  \n[https://doi.org/10.1002/ctm2.1692](https://doi.org/10.1002/ctm2.1692)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nDOI: 10.1002/ctm2.1692  \nRESEARCH ARTICLE  \nInhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer  \nXin Guan1,2, 3  Yuanyu Liao1,2, 3  \nRuiqi Liu4  Bojun Wang1,2, 3  Yuli Ruan1,2, 3  Lin Fang5  \nRuxin Xiong1,2, 3  Luying Cui1,2, 3 Xiaolin Lu6  Xuefan Yu1,2, 3   \nDan Su1,2, 3  Yue Ma1,2, 3  Tianjiao Dang1,2, 3  Zhuo Chen1,2, 3  Yuanfei Yao1,2, 3  Chao Liu1,2, 3  Yanqiao Zhang1,2, 3   \n1 Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China  \n2 Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China  \n3 Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China  \n4 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China  \n5 Phase I Clinical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China  \n6 Department of Orthopedic Surgery, Harbin Medical University Cancer Hospital, Harbin, China  \nCorrespondence  \nYanqiao Zhang, Chao Liu and Yuanfei Yao, Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150001, China.  \nEmail:  \n[yanqiaozhang@ems.hrbmu.edu.cn](yanqiaozhang@ems.hrbmu.edu.cn);  \n[liuchao@hrbmu.edu.cn](liuchao@hrbmu.edu.cn); [yaoyuanfei@hrbmu.edu.cn](yaoyuanfei@hrbmu.edu.cn)  \nFunding information  \nNational Natural Science Foundation of China, Grant/Award Numbers:  \nU22A20330, 82173233, 82373372, 82102858, 82102988; Key Project of Research and Development Plan in Heilongjiang Province, Grant/Award Number:  \n2022ZX06C01; Natural Science Funding of Heilongjiang, Grant/Award Number: YQ2022H017; Harbin Medical University Cancer Hospital, Grant/Award Number: BJQN2021-01; Top Young Talents Project  \nAbstract  \nBackground: Although numerous studies have indicated that activated pyroptosis can enhance the efficacy of antitumour therapy in several tumours, the precise mechanism of pyroptosis in colorectal cancer (CRC) remains unclear. Methods: Pyroptosis in CRC cells treated with antitumour agents was assessed using vari","cbCaigJmHbjhn1pG","https://ap.wps.com/l/cbCaigJmHbjhn1pG","pdf",16625581,23,"English","# Background and Research Question\n# Methods\n## Experimental assays and molecular analyses\n## Validation models\n# Results\n## NLRP3 and GSDMD-mediated pyroptosis outcomes\n## HDAC2 epigenetic regulation mechanism\n# Conclusion and Therapeutic Implications","[{\"question\":\"Why is pyroptosis considered important for antitumour therapy in colorectal cancer?\",\"answer\":\"Activated pyroptosis can enhance antitumour efficacy in multiple cancers, but the precise mechanism in colorectal cancer is unclear. This work targets that missing mechanistic link.\"},{\"question\":\"How did the study assess pyroptosis in colorectal cancer cells?\",\"answer\":\"Pyroptosis after antitumour treatment was evaluated using Western blotting, lactate dehydrogenase (LDH) release assays, and microscopy.\"},{\"question\":\"What role does HDAC2 play in regulating NLRP3 and pyroptosis?\",\"answer\":\"HDAC2 suppresses NLRP3 transcription through epigenetic regulation, limiting NLRP3-dependent, GSDMD-mediated pyroptosis. Inhibiting HDAC2 activates pyroptosis and improves therapeutic effects, supported by molecular and in vivo evidence.\"}]","Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer | PDF",1790030486,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab24d94fabd0decb19712fb8b27f2fc3.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5582ec8f0481bd19105cf1b8500fb54.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bc744190770556829491e06e46ac121.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6852b8a0c60d0528c4bb858a5b8184b2.webp",980,1287]